Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 23.05.2024
Asklepios Kliniken
Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024
Consolidated revenue up year-on-year at EUR 1,414.5 million
Consolidated net income (EAT) of EUR 18.5 million
Increase in patient and employee numbers
Hamburg, 23 May 2024. Asklepios Kliniken GmbH & Co. KGaA has enjoyed a solid economic performance i [ … ]
Thu, 23.05.2024
Money20/20
EQS Newswire / 23/05/2024 / 10:00 CET/CEST
LONDON, UK - Media OutReach Newswire - 23 May 2024 - Money20/20, the world's leading fintech show, and the place where money does business, unveils its dynamic agenda for its upcoming Europe show in Amsterdam, 4-6 June. The agenda will explore how advanced analytics and technologies can be used to an [ … ]
Thu, 23.05.2024
Nabaltec AG
Nabaltec AG publishes report for the first quarter of 2024: earnings nearly on par with last year, with a slight decline in revenues
Consolidated revenues in the first three months of 2024 at EUR 54.0 million (-5.3% compared to the same quarter of the previous year)
EBIT of EUR 5.0 million in the first three months of 2024 (Q1/2023: EUR 5.2 mill [ … ]
Thu, 23.05.2024
Nabaltec AG
Nabaltec AG publishes report for the first quarter of 2024: earnings nearly on par with last year, with a slight decline in revenues
Consolidated revenues in the first three months of 2024 at EUR 54.0 million (-5.3% compared to the same quarter of the previous year)
EBIT of EUR 5.0 million in the first three months of 2024 (Q1/2023: EUR 5.2 mill [ … ]
Thu, 23.05.2024
JP Jenkins Ltd
23rd May 2024
JPJ:ETX
ISIN: GB00B2823H99
e-therapeutics plc
("e-therapeutics" or “ETX” or the "Company")
Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors
London, UK, 23 May 2024 – e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNA [ … ]
Thu, 23.05.2024
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
Ladenburg, Germany, 23 May 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), is pleased to announce that its management team will be participating [ … ]
Thu, 23.05.2024
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
Ladenburg, Germany, 23 May 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), is pleased to announce that its management team will be participating [ … ]
Thu, 23.05.2024
USU Software AG
Sales increase from 6.3% to EUR 35.4 million
License sales more than tripled to EUR 4.5 million
SaaS revenue increases by 10.4% to EUR 4.4 million
EBITDA grows by 20.6% to EUR 4.6 million
Record orders at hand of EUR 96.9 million
public delisting takeover offer to USU shareholders announced
Möglingen, 23 May 2024.
In the first quarter of [ … ]
Thu, 23.05.2024
Einhell Germany AG
Q1 in line with expectations // FY24e guidance confirmed
Einhell released Q1 results in line with expectations, showing healthy top
and bottom line growth versus Q1’23 and Q4’23. Despite an ongoing depressed
consumer sentiment, sales grew by 7.8% yoy to € 270m (eNuW: € 265m), driven
by higher demand for the company’s [ … ]
Thu, 23.05.2024
2G Energy AG
2G Energy AG noticeably improves cost of materials ratio in the first quarter and substantially increases EBIT
Cost of materials ratio drops to 64.5% (previous year: 69.0%)
EBIT of EUR 0.9 million marks a significant increase over the previous year (EUR -0.2 million)
Sales revenues remain at a very high level at EUR 69.5 million (previous year: [ … ]